Exhibit 10.3
Execution Copy
AMENDED AND RESTATED
INVESTORS AGREEMENT
by and among
ALLEGIANT TRAVEL COMPANY,
LLC
PURCHASERS OF SERIES A PREFERRED
SHARES
and
HOLDERS OF SERIES B PREFERRED
SHARES
AND COMMON SHARES
of
ALLEGIANT TRAVEL COMPANY,
LLC
and
PAR INVESTMENT PARTNERS,
L.P.
Dated as of May 4, 2005
and
Amended and Restated as of December
13 th , 2006
TABLE OF CONTENTS
|
|
|
|
|
Page
|
|
|
|
|
|
|
|
1.
|
|
Definitions
|
|
2
|
|
|
|
|
|
|
|
2.
|
|
Voting Agreement
|
|
5
|
|
|
|
|
|
|
|
3.
|
|
Transfers of Shares
|
|
9
|
|
|
|
|
|
|
|
4.
|
|
Exempt Transfers
|
|
12
|
|
|
|
|
|
|
|
5.
|
|
Preemptive Rights
|
|
13
|
|
|
|
|
|
|
|
6.
|
|
Registration Rights
|
|
15
|
|
|
|
|
|
|
|
7.
|
|
Market Agreements
|
|
26
|
|
|
|
|
|
|
|
8.
|
|
Clawback Provision
|
|
27
|
|
|
|
|
|
|
|
9.
|
|
Compliance with Securities Laws
|
|
27
|
|
|
|
|
|
|
|
10.
|
|
Execution by the Company
|
|
29
|
|
|
|
|
|
|
|
11.
|
|
Enforcement
|
|
30
|
|
|
|
|
|
|
|
12.
|
|
Miscellaneous
|
|
31
|
SCHEDULE A – LIST OF EXISTING
HOLDERS
SCHEDULE B –
INVESTORS
EXHIBIT A – INSTRUMENT OF
ACCESSION
EXHIBIT B – TERMS OF PLAN OF
DISTRIBUTION
i
AMENDED AND RESTATED INVESTORS
AGREEMENT
THIS AMENDED AND RESTATED INVESTORS
AGREEMENT (the “ Agreement ”) is made as
of December 13, 2006 by and among ALLEGIANT TRAVEL COMPANY,
LLC, a Nevada limited liability company (the “
Company ”), the holders of Common Shares and
Series B Shares of the Company listed on Schedule A hereto
(together with any Permitted Transferee of the Existing Holder
Shares (as herein defined) of any such person and together with any
Person who becomes subject to the provisions hereof pursuant to the
provisions of this Agreement, the “ Existing
Holders ”), the investors listed on Schedule B hereto
(together with any Permitted Transferee of any such person, each,
an “ Investor ” and together with the
Existing Holders, each a “ Member ,” and
collectively, the “ Members ”) and PAR
INVESTMENT PARTNERS, L.P., a Delaware limited partnership (“
PAR ”).
RECITALS:
A.
The Investors entered into a Securities Purchase Agreement with the
Company’s subsidiary, Allegiant Air, LLC, (the “
Purchase Agreement ”) and a subsequent letter
agreement with the Company providing, among other things, for the
sale of shares of the Company’s Series A Shares (as herein
defined) and, in connection with that agreement and as an
inducement to the Investors to purchase the Series A Shares, the
Company and the Members entered into an Investors Agreement dated
as of May 4, 2005 (the “ Original Agreement
”).
B.
The Company operates a low-cost passenger airline marketed to
leisure travelers in small cities (the “
Business ”).
C.
In connection with the initial public offering (the “
IPO ”) of the common stock, par value $.001 per
share (the “ Common Stock ”), of
Allegiant Travel Company, a Nevada corporation and a wholly-owned
subsidiary of the Company (“ Allegiant ”)
pursuant to a registration statement on Form S-1 (Reg. No.
333-134145) (the “ Initial Registration
Statement ”), the Company will complete a
reorganization transaction (the “
Reorganization ”) whereby Allegiant will
succeed to the Business of the Company and the members of the
Company will become stockholders of Allegiant.
D.
The Reorganization will be accomplished through a merger (the
“ Merger ”) of the Company with and into
Allegiant and the members of the Company will receive shares of
Common Stock of Allegiant in exchange for their shares of preferred
and common membership interests in the LLC.
E.
The members of the Company will become record owners of shares of
Common Stock of Allegiant upon completion of the
Reorganization.
F.
In connection with the closing of the IPO, PAR is purchasing
certain of the shares of Common Stock of Allegiant that the members
of the Company receive in the Reorganization.
G.
The parties to the Original Agreement desire to amend and restate
the Original Agreement to add PAR as a party and to grant PAR
certain registration rights.
1
NOW, THEREFORE, in consideration of
the mutual covenants set forth herein, and for other good and
valuable consideration, the receipt and sufficiency of which are
acknowledged, and intending to be legally bound, the parties hereto
amend and restate the Original Agreement and agree as
follows:
This Amended and Restated Investor
Agreement shall become effective only upon the closing of the IPO.
The parties hereto acknowledge that the IPO qualifies as a
Qualified Public Offering. The parties hereto further acknowledge
that the clawback obligations set forth in Section 8 hereof will be
satisfied through the consummation of the Merger. From and after
consummation of the Merger, (i) the term “Company,” as
used herein, shall mean Allegiant, as the surviving corporation in
the Merger, and (ii) the term “Common Shares,” as used
herein, shall mean the shares of Common Stock, par value $0.001 per
share, of Allegiant issued pursuant to the Merger. For purposes of
this Agreement, the term “ Member ” shall
not include PAR.
1.
Definitions . As used in this Agreement, the
following capitalized terms are defined as provided in this
Section 1 :
“ Affiliate
” shall mean, with respect to any Person, any Person that
directly or indirectly, through one or more intermediaries,
Controls, is Controlled by, or is under common Control with such
Person, including, but not limited to, any executive officer or
director of such Person or any holder of ten percent (10%) or more
of the outstanding equity or voting power of such
Person.
“ Board ”
means the managing board of the Company.
“ Certificate of
Determination ” means the Certificate of
Determination of Voting Powers, Designations, Preferences,
Limitations, Restrictions and Relative Rights of Series A
Convertible Preferred Shares and Series B Convertible Preferred
Shares of the Company.
“ Common Shares
” means shares of common equity of the Company.
“ Company
Securities ” means, collectively, Common Shares,
Series A Shares and Series B Shares.
“ ComVest
” means ComVest Allegiant Holdings LLC or its Permitted
Transferees.
“ Control
” shall mean possession, directly or indirectly, of power to
direct or cause the direction of management or policies (whether
through ownership of voting securities, by agreement or
otherwise).
“ Conversion
Shares ” shall mean the total number of Common Shares
an owner of Preferred Shares would receive at a particular time
upon conversion of all of his Preferred Shares into Common
Shares.
2
“ Darley ”
means Darley Properties Limited or its Permitted
Transferees.
“ Director
” shall mean any individual serving on the Board of the
Company.
“ Existing Holder
Shares ” means any Common Shares or Series B Shares
now owned or subsequently acquired by any Existing Holder or his
successors, transferees or assigns.
“ Investor
Director ” means each Person elected to the Board
pursuant to Section 2(a)(i) .
“ Member Notice
” means written notice from a Member notifying the Company
and the selling Member that such Member intends to exercise its
Right of First Refusal as to a specified number of shares of the
Transfer Securities with respect to any Proposed
Transfer.
“ New Securities
” means any equity securities of the Company, whether now
authorized or not, or rights, options, or warrants to purchase such
equity securities, or securities of any type whatsoever that are,
or may become, convertible into or exchangeable into or exercisable
for such equity securities other than exempt issuances described in
Section 5(b) .
“ Percentage
Ownership ” of a Member shall be equal to the number
of such Member’s Common Shares and Conversion Shares divided
by the total number of Common Shares and Conversion Shares owned by
all Members.
“ Permitted
Transferee ” means any Person holding shares of
capital of the Company which have been transferred to such Person
in accordance with the terms and conditions of the Company’s
Operating Agreement, this Agreement and applicable securities
laws.
“ Person ”
means any individual, corporation, limited liability company,
partnership, trust, unincorporated association, business or other
legal entity and any government or governmental agency or political
subdivision thereof.
“ Preferred
Shares ” means, collectively, Series A Shares and
Series B Shares.
“ Proposed
Transfer ” means any proposed assignment, sale, offer
to sell, disposition or any other like transfer of any Common
Shares or Preferred Shares of the Company (or any interest
therein), in each case arising from a bona fide transaction with a
third party, actual or proposed by any of the Members (or to which
any of the Members is subject) that is not exempt from restrictions
on transfer under Section 4 of this Agreement.
“ Proposed Transfer
Notice ” means written notice from a Member, setting
forth the terms and conditions of a Proposed Transfer.
“ Prospective
Transferee ” means any Person to whom a Member
proposes to make a Proposed Transfer.
3
“ Public
Offering ” shall mean a firm commitment underwritten
public offering registered under the Securities Act covering the
offer and sale by the Company of its Common Shares.
“ Qualified Public
Offering ” shall mean a Public Offering: (a) in which
(i) the aggregate proceeds to the Company equal or exceed
$30,000,000 before deduction for underwriting discounts,
commissions and fees, and (ii) the price per share of such Common
Shares before deduction for underwriting discounts and commissions,
equals or exceeds $5.00 per Share (such price subject to equitable
adjustment in the event of any share split, share dividend,
combination, recapitalization, reorganization, reclassification or
other similar event), and (b) that results in the securities so
offered being listed on a national securities exchange or quoted on
the NASDAQ National Market.
“ Right of
Co-Sale ” means the right, but not an obligation, of
an Investor to participate in a Proposed Transfer on the terms and
conditions specified in the applicable Proposed Transfer
Notice.
“ Right of First
Refusal ” means the right, but not an obligation, of
each Member to purchase up to its pro rata portion (based upon the
total number of Common Shares and Conversion Shares of such Member
as compared to the total number of Common Shares and Conversion
Shares of all Members) of any Transfer Securities with respect to a
Proposed Transfer, on the terms and conditions specified in the
Proposed Transfer Notice.
“ Securities Act
” means the Securities Act of 1933, as amended.
“ Series A
Shares ” means shares of Series A Convertible
Preferred Shares of the Company.
“ Series B
Holders ” means the holders of the Series B
Shares.
“ Series B
Shares ” means shares of Series B Convertible
Preferred Shares of the Company.
“ Shares ”
means shares of capital of the Company at any time outstanding
including Common Shares, Preferred Shares and Common Shares issued
or issuable upon exercise or conversion, as applicable, of share
options, warrants or other convertible securities of the Company,
in each case now owned or subsequently acquired by any Member, or
such Member’s successors, Permitted Transferees or
assigns.
“ Transfer
Securities ” means Common Shares or Preferred Shares
subject to a Proposed Transfer.
“ Undersubscription
Notice ” means written notice from an Investor
notifying the Company and the selling Member that such Investor
intends to exercise its option to purchase a portion of the
Transfer Securities not purchased pursuant to the Right of First
Refusal.
4
2.
Voting Agreement .
(a)
Board Composition . Each Member shall vote all of his, her
or its Shares, whether now owned or hereafter acquired or which
such Member may be empowered to vote, from time to time and at all
times, in whatever manner shall be necessary to ensure that at each
annual or special meeting of Members of the Company at which an
election of Directors is held or pursuant to any written consent of
the Members of the Company, the following persons shall be elected
to the Board:
(i)
At each election of Directors in which the holders of Series A
Shares, voting as a separate class, are entitled to elect Directors
of the Company, (A) two (2) individuals (the “ ComVest
Directors ”) designated by ComVest, which individuals
shall initially be Robert L. Priddy and Michael S. Falk and (B) one
individual (the “ Darley Director ”),
which individual shall initially be Declan Ryan (the ComVest
Directors and Darley Director being sometimes referred to
collectively as the “ Investor Directors
” or individually as an “ Investor
Director ”);
(ii)
At each election of Directors in which the holders of Series B
Shares and Common Shares, voting as a separate class, are entitled
to elect Directors of the Company, three (3) individuals (the
“ Common Directors ”) designated by the
holders of the Series B Shares and Common Shares, voting as a
separate class, one of which individuals shall initially be Maurice
J. Gallagher, Jr. (“ Gallagher ”);
and
(iii)
One (1) independent Director (the “ Independent
Director ”) selected by mutual agreement of a
majority in interest of the Series B Holders and a majority in
interest of the Investors.
At any time the Board seat for the
second or third Common Director remains vacant, any such Common
Director may be selected by a majority in interest of the Series B
Holders. The selection shall be evidenced by a written notice
delivered by a majority in interest of the Series B Holders to the
Company, ComVest and Darley.
At any time the Board seat for the
Independent Director remains vacant, a majority interest of the
Investors or a majority interest of the Series B Holders may
propose a name to serve in such position. Upon approval by both a
majority interest of the Investors and a majority interest of the
Series B Holders, such individual shall be added to Board
immediately to fill such vacancy.
(b)
Removal of Board Members .
(i)
The Board shall have the right to remove any Director for Cause
upon a vote of at least 70% of all of the members of the Board,
excluding the Board member whose removal is being voted upon. For
these purposes, “ Cause ” shall be
defined as (i) commission of a felony or other act involving moral
turpitude, which other act is materially detrimental to the
Company; (ii) commission of any act, specifically including but not
limited to, drug or alcohol abuse, which act is materially harmful
to the Company, or which in the reasonable opinion of the Board
brings the Company into disrepute; (iii) commission of any act of
fraud, dishonesty, theft or misappropriation, whether or not
related to his activities on behalf of the Company; (iv) breach of
any duty of confidentiality to the Company; or (v) material breach
of the fiduciary duty owed to all Members of the
Company.
5
(ii)
Each Member shall vote all of his, her or its Shares from time to
time and at all times in whatever manner as shall be necessary to
ensure (A) that no Director elected pursuant to Section 2(a)
of this Agreement may be removed from office other than for Cause
or as provided in (B) or (C) below, (B) the removal of a Director
elected pursuant to Section 2(a)(i) , which removal is
directed or approved by the affirmative vote of the Members
entitled under Section 2(a)(i) to designate that
Director, (C) removal of a Director elected pursuant to Section
2(a)(ii) , which removal is directed or approved by the
affirmative vote of the Members entitled under Section
2(a)(ii) to designate such Director, and (D) that any vacancies
created by the resignation, removal or death of a Director elected
pursuant to Section 2(a) shall be filled pursuant to the
provisions of Section 2(a) . Each Member shall execute any
written consents required to effectuate the obligations of this
Agreement, and the Company shall, at the request of any Member
entitled to designate a Director, call a special meeting of Members
for the purpose of electing Directors.
(c)
Notice of Elections . The Company shall provide the holders
of Series A Shares with 30 days’ prior written notice of any
intended mailing of a notice to holders of Series A Shares for any
meeting of the Company’s Members at which Directors are to be
elected. The Members entitled to designate a Director pursuant to
Section 2(a) shall give written notice to the Company, no
later than 20 days prior to such mailing, of the individual(s)
designated by such Members as nominees for election as Directors.
The Company shall nominate and recommend for election as Directors
only the individuals designated, or to be designated, pursuant to
Section 2(a) . If the Members entitled to designate a
Director pursuant to Section 2(a) shall fail to give notice
to the Company as provided above in this Section 2(c) , it
shall be deemed that the designees of such Members then serving as
Directors shall be their designees for reelection. Notwithstanding
the foregoing, the notice provisions hereof shall not apply to the
election of Directors by written consent of the Company’s
Members.
(d)
Termination of Board Rights . The obligations to vote and
the rights granted pursuant to Sections 2(a) through
2(c) shall terminate upon consummation of a Qualified Public
Offering.
(e)
Directors’ Liability and Indemnification . The
Operating Agreement of the Company (“ Operating
Agreement ”) shall provide (a) for elimination of the
liability of Directors to the maximum extent permitted by law, and
(b) that the Company shall be authorized to indemnify Directors for
acts on behalf of the Company to the maximum extent permitted by
law. The Members acknowledge and agree that the Company does not
intend to maintain directors and officers liability insurance prior
to a Public Offering. At the request of any Director designated to
serve on the Board in accordance with this Agreement, the Company
shall enter into an indemnification agreement with such Director in
form reasonably satisfactory to such director and the Company
confirming that such Director is entitled to indemnification to the
maximum extent permitted by law.
(f)
Confidentiality; Conflict of Interest . Each Director shall
be required to execute and deliver to the Company a confidentiality
agreement protecting confidential information of the Company and
the Company’s conflict of interest policy assuring that the
Director does not have any conflict of interest that may impair the
Director’s exercise of his fiduciary duty to the Members,
such documents to be in such form as may be approved by the Board
of the Company.
6
(g)
Drag-Along Right . In the event that Members holding at
least 66 2/3% of the Shares (the “ Requisite
Members ”) approve either:
(A)
a transaction or series of related transactions in which a Person,
or two or more Persons who agree to act together to acquire, hold,
vote or dispose of any securities of the Company, would acquire
from the Company or from Members of the Company shares representing
fifty percent (50%) or more of the outstanding voting power of the
Company, or
(B)
a transaction that would qualify as a “
Liquidation ” as defined in the Company’s
Certificate of Determination
(such events described in
subsections (A) and (B) are referred to in this Agreement as a
“ Sale of the Company ”), then each
Member shall, with respect to all Shares that he, she or it holds
and any other Company Securities over which he, she or it otherwise
exercises dispositive power:
(i)
in the event that a Sale of the Company is submitted for the
approval of Members after receiving proper notice in accordance
with Section 2(c), vote (in person, by proxy or by action by
written consent, as applicable) all Shares in favor of such Sale of
the Company and in opposition to any and all other proposals that
could reasonably be expected to delay or impair the ability of the
Company to consummate such Sale of the Company;
(ii)
in the event that a Sale of the Company is to be effected by the
sale of the Shares, sell all Shares beneficially held by such
Member (or in the event that the Requisite Members are selling
fewer than all of their Shares, Shares in the same proportion as
the Requisite Members are selling) to the Person(s) to whom the
Requisite Members propose to sell their Shares, for the same
per-share consideration (on an as-converted basis) and on the same
relative terms and conditions as the Requisite Members, except that
the aggregate consideration to be received by the Members in
connection with any such Sale of the Company shall be allocated and
distributed in the same manner as provided upon a Liquidation as
set forth in the Company’s Certificate of
Determination;
(iii)
refrain from exercising any dissenters’ rights or rights of
appraisal under applicable law at any time with respect to such
Sale of the Company;
(iv)
execute and deliver all related documentation and take such other
action in support of such Sale of the Company as shall reasonably
be requested by the Company, including the execution of such
agreements and such instruments and other actions reasonably
necessary to effectuate the allocation and distribution of the
aggregate consideration upon such Sale of the Company, provided
that no Member shall be required to incur any obligation in
connection with such Sale of the Company other than such
obligations as may be incurred by all Members in proportion to
their interests in the Company; and
(v)
not deposit, and cause their Affiliates not to deposit, except as
provided in this Agreement, any voting securities owned by such
Member or Affiliate in a voting trust or, except as provided in
this Agreement, subject any such voting securities to any
arrangement or agreement with respect to the voting of such shares,
unless specifically requested to do so by the acquirer in
connection with such Sale of the Company.
7
The provisions of this Section
2(g) shall terminate upon consummation of a Qualified Public
Offering.
(h)
Increase in Authorized Capital; Further Issuances . Each
Member shall vote all of his, her or its Shares from time to time
and at all times, in whatever manner necessary to authorize an
increase in the authorized capital of the Company so that there
will be sufficient Common Shares available for conversion of all of
the then outstanding Preferred Shares, at any time that an
adjustment to the Conversion Price (as defined in the
Company’s Certificate of Determination) is made pursuant to
the Company’s Certificate of Determination. In the event the
Board approves an equity financing plan or arrangement involving an
(i) increase in the number of authorized shares of any class or
series of capital of the Company, (ii) the creation of any new
class or series of equity of the Company, and/or (iii) the issuance
of additional shares of capital of the Company (whether or not such
issuance requires any action set forth in either of the preceding
items (i) or (ii)) and such action is also approved as required (if
required) under the terms of the Certificate of Determination, each
Member shall, with respect to all Shares that he, she or it holds
and any other Company securities over which he, she or it otherwise
exercises voting power: (A) be present, in person or by proxy, as a
holder of Shares, at any and all meetings of Members duly called
and noticed for the approval of such plan or arrangement and be
counted for the purposes of determining the presence of a quorum at
such meetings so long as the Member votes in favor of such plan or
arrangement (otherwise, the Member agrees not to be present, in
person or by proxy at such meetings), (B) vote (in person, by proxy
or by action by written consent, as applicable) all Shares in favor
of or not in opposition to such plan or arrangement, (C) vote (in
person, by proxy or by action by written consent) in opposition to
any and all other proposals that could reasonably be expected to
delay or impair the ability of the Company to consummate such plan
or arrangement, and (D) execute and deliver all related
documentation and take such other action in support of such
financing as may be requested by the Board, including the execution
of such agreements and other instruments, including but not limited
to, amendments and modifications to this Agreement as may be
necessary to effectuate such financing.
(i)
Covenants of the Company . The Company shall use its best
efforts to ensure that the rights granted under this Agreement are
effective and that the Members enjoy the benefits of this
Agreement. Such actions include, without limitation, the use of the
Company’s best efforts to cause the nomination and election
of the Directors as provided above. The Company will not, by any
voluntary action, avoid or seek to avoid the observance or
performance of any of the terms to be performed hereunder by the
Company, but will at all times in good faith assist in the carrying
out of all of the provisions of this Agreement.
(j)
Manner of Voting . The voting of Shares pursuant to this
Agreement may be effected in person, by proxy, by written consent
or in any other manner permitted by applicable law.
(k)
Stock Option Plans and Employment Agreements . In no event
shall the Company implement any new stock option or bonus plan or
enter into any new employment arrangements unless and until
approved by a majority of the members of the Board.
8
3.
Transfers of Shares .
(a)
Right of First Refusal .
(1)
Grant . No Existing Holder shall pledge or otherwise
encumber any Company Securities held by such Existing Holder except
that this restriction shall not apply to Shares that have
heretofore been pledged by Mitch Allee (“ Allee
”) to Gallagher. Each Existing Holder hereby unconditionally
and irrevocably grants to all Members a Right of First Refusal to
purchase all or any portion of the Transfer Securities that such
Existing Holder may propose to transfer in a Proposed Transfer, at
the same price and on the same terms and conditions as those
offered to the Prospective Transferee.
(2)
Notice . Each Existing Holder proposing to make a Proposed
Transfer shall deliver a Proposed Transfer Notice to the Company
and to each other Member not later than 30 days prior to the
consummation of such Proposed Transfer. Such Proposed Transfer
Notice shall contain the material terms and conditions of the
Proposed Transfer and the identity of the Prospective Transferee.
To exercise its Right of First Refusal, a Member shall deliver a
Member Notice to the selling Existing Holder and the Company within
15 days after delivery of the Proposed Transfer Notice (such 15-day
period, the “ Notice Period
”).
(3)
Undersubscription of Transfer Securities . If by the end of
the Notice Period, the Members, or any of them, have exercised
their respective rights to purchase Transfer Securities with
respect, in the aggregate, to some but not all of the Transfer
Securities, then the Company shall, immediately after the
expiration of the Notice Period, send written notice to those
Members who fully exercised their options within the Notice Period
(the “ Exercising Members ”). Each
Exercising Member shall have an additional option to purchase all
or any part of the balance of any such remaining unsubscribed
shares of Transfer Securities on the terms and conditions set forth
in the Proposed Transfer Notice. To exercise such option, an
Exercising Member shall deliver an Undersubscription Notice to the
selling Existing Holder and the Company within 15 days after the
expiration of the Notice Period. In the event there are two or more
such Exercising Members that choose to exercise the last-mentioned
option for a total number of remaining shares of Transfer
Securities in excess of the number available, the remaining shares
of Transfer Securities available for purchase under this Section
3(b)(3) shall be allocated to such Exercising Members pro rata
based on the number of shares of Transfer Securities such
Exercising Members have elected to purchase. If the options to
purchase the remaining shares of Transfer Securities are exercised
in full by the Exercising Members, the Company shall immediately
notify all of the Exercising Members of that fact. If the options
to purchase the remaining shares of Transfer Securities are not
exercised in full by the Exercising Members, then the Company shall
have the right to purchase all or any part of the balance of any
such remaining unsubscribed shares of Transfer Securities on the
terms and conditions set forth in the Proposed Transfer
Notice.
(4)
Oversubscription of Transfer Securities . In the event more
than one Member elects to purchase any or all of the shares of
Transfer Securities specified in the Proposed Transfer Notice and
such elections to purchase aggregate more than the number of shares
of Transfer Securities, each such Member shall be entitled to
purchase from the selling Existing Holder a pro rata portion (based
upon the number of Common Shares and Conversion Shares of such
Member as compared to the number of Common Shares and Conversion
Shares of all Exercising Members) of such Transfer Securities, up
to the number of shares specified in
9
such Exercising Member’s
election. Any shares of Transfer Securities not so allocated shall
be allocated as aforesaid in one or more successive allocations to
each Exercising Member whose election specified a number of shares
greater than the number which had then been allocated to such
Exercising Member, until all of the shares of Transfer Securities
have been allocated.
(5)
Consideration; Closing . If the consideration proposed to be
paid for the Transfer Securities is in property, services or other
non-cash consideration, and any Exercising Member (or the Company)
cannot for any reason pay for the Transfer Securities in the same
form of non-cash consideration, such Exercising Member (or the
Company) may pay the cash value equivalent thereof, as determined
by the Board. The closing of the purchase of Transfer Securities by
the Exercising Members (or the Company) shall take place, and all
payments from the Exercising Members (or the Company) shall be
delivered to the selling Existing Holder by the later of (i) the
date specified in the Proposed Transfer Notice as the intended date
of the Proposed Transfer, and (ii) forty-five (45) days after
delivery of the Proposed Transfer Notice.
(b)
Right of Co-Sale .
(1)
If any Transfer Securities subject to a Proposed Transfer by any
Existing Holder are not purchased in whole by one or more Members
(or the Company) pursuant to Section 3(a) above and
thereafter are to be sold to a Prospective Transferee, each
Investor who has chosen not to exercise a right to purchase such
Transfer Securities may elect to exercise its Right of Co-Sale and
participate on a pro-rata basis in the Proposed Transfer on the
same terms and conditions specified in the Proposed Transfer
Notice. Each Investor who desires to exercise its Right of Co-Sale
shall give the selling Existing Holder written notice to that
effect on or before the deadline for delivery of the
Undersubscription Notice, and upon giving such notice such Investor
will be deemed to have effectively exercised the Right of
Co-Sale.
(2)
Each Investor who timely exercises its Right of Co-Sale by
delivering the written notice provided for in Section
3(b)(1) (each, a “ Co-Selling Investor
”) may include in the Proposed Transfer, all or any part of
its Shares equal to the product obtained by multiplying (i) the
aggregate number of Common Shares or Preferred Shares proposed to
be transferred (excluding shares purchased by the Company or the
Members pursuant to the Right of First Refusal) by (ii) a fraction,
the numerator of which is the number of Common Shares and
Conversion Shares of such Co-Selling Investor immediately before
consummation of the Proposed Transfer and the denominator of which
is the total number of Common Shares and Conversion Shares, in the
aggregate, of all Co-Selling Investors immediately prior to the
consummation of the Proposed Transfer, plus the number of Common
Shares and Conversion Shares owned by the selling Existing Holder.
To the extent one or more of the Investors exercise such right of
participation in accordance with the terms and conditions set forth
herein, the number of Shares that the selling Existing Holder may
sell in the Proposed Transfer shall be correspondingly
reduced.
(3)
Each Co-Selling Investor shall effect its participation in the
Proposed Transfer by making reasonable arrangements, no later than
15 days after such Co-Selling Investor’s exercise of the
Right of Co-Sale, to deliver to the transferring Member one or more
share certificates, properly endorsed for transfer to the
Prospective Transferee representing
10
the number of Common Shares or
Series A Shares, as applicable, that such Co-Selling Investor
elects to include in the Proposed Transfer. The Company shall make
any conversion required by an Investor to exercise its Right of
Co-Sale concurrent with and contingent upon the actual transfer of
such shares to the Prospective Transferee.
(4)
The terms and conditions of any sale pursuant to this Section
3(b) will be on the terms and conditions specified in the
Proposed Transfer Notice.
(5)
Each share certificate a Co-Selling Investor delivers pursuant to
subparagraph (3) above will be transferred to the Prospective
Transferee against payment therefor in consummation of the sale of
the Transfer Securities pursuant to the terms and conditions
specified in the Proposed Transfer Notice and the purchase and sale
agreement, and the selling Existing Holder shall concurrently
therewith remit to each Co-Selling Investor the portion of the sale
proceeds to which such Co-Selling Investor is entitled by reason of
its participation in such sale. If any Prospective Transferee or
Transferees refuse(s) to purchase Shares subject to the Right of
Co-Sale from any Co-Selling Investor exercising its Right of
Co-Sale hereunder, no Existing Holder may sell any Company
Securities to such Person unless and until, simultaneously with
such sale, such Existing Holder purchases all Shares subject to the
Right of Co-Sale from such Co-Selling Investor.
(6)
If any aspect of any Proposed Transfer is not consummated with the
original Prospective Transferee, or with or by any Investor
exercising any rights under this Section 3 , within 90 days
after the expiration of the Right of First Refusal, the Existing
Holder proposing the Proposed Transfer may not sell any Company
Securities unless it first complies in full with each provision of
this Section 3 . The exercise or election not to exercise
any right by any Member hereunder shall not adversely affect its
right to participate in any other sales of Transfer Securities
subject to Section 3 .
(c)
Transfers by Investors . Any Investor may transfer any
portion or all of its Series A Shares to an Affiliate or to another
transferee subject to the following: (i) the transfer complies with
all applicable state and federal securities laws and the Investor
furnishes to the Company a legal opinion to that effect in a form
reasonably satisfactory to the Company; (ii) the transfer does not
jeopardize the Company’s characterization as a U.S. Air
Carrier as a result of foreign ownership of Shares in the Company;
(iii) the Board determines in good faith that ownership of Shares
in the Company by the Prospective Transferee could have a
detrimental effect on the business of the Company; and (iv) the
transferee agrees to be bound by the terms of this Agreement and
the Operating Agreement. Any Investor seeking to transfer Shares in
the Company agrees to provide the Company with any information
reasonably requested by the Company concerning the Prospective
Transferee or the Proposed Transfer.
(d)
Effect of Failure to Comply .
(1)
Any Proposed Transfer not made in compliance with the requirements
of this Agreement shall be null and void ab initio, shall not be
recorded on the books of the Company or its transfer agent and
shall not be recognized by the Company. Each party hereto
acknowledges and agrees that any breach of this Agreement would
result in substantial harm to the other parties hereto for which
monetary damages alone could not
11
adequately compensate. Therefore,
the parties hereto unconditionally and irrevocably agree that any
non-breaching party hereto shall be entitled to seek protective
orders, injunctive relief and other remedies available at law or in
equity (including, without limitation, seeking specific performance
or the rescission of purchases, sales and other transfers not made
in strict compliance with this Agreement).
(2)
If any Member purports to sell any Shares in contravention of the
Right of Co-Sale (a “ Prohibited Transfer
”), each Investor, in addition to such remedies as may be
available by law, in equity or hereunder, is entitled to require
such Member to purchase Shares from such Investor as provided
below, and such Member will be bound by the terms of such option.
If a Member makes a Prohibited Transfer, each Investor who timely
exercises its Right of Co-Sale under Section 3(b) may
require such Member to purchase from such Investor the type and
number of Shares that such Investor would have been entitled to
sell under Section 3(b) had the Prohibited Transfer been
effected pursuant to and in compliance with the terms of Section
3(b) .
(3)
Within 90 days after the date on which an Investor received notice
of the Prohibited Transfer or otherwise became aware of the
Prohibited Transfer, such Investor shall, if exercising the option
created hereby, make reasonable arrangements to deliver to the
selling Member, the certificate or certificates representing the
Shares to be transferred, each certificate to be properly endorsed
for transfer.
(4)
Such selling Member shall, upon receipt of the certificate or
certificates for the Shares to be transferred by an Investor
pursuant to this Section 3(c) , pay the aggregate purchase
price therefor in cash or by other means acceptable to such
Investor.
(e)
Expiration of Rights . The respective rights of the Members
under this Section 3 shall not apply to the sale of up to
1,750,000 shares to PAR simultaneously with the initial Public
Offering of the Company and shall expire upon the consummation of a
Qualified Public Offering.
4.
Exempt Transfers .
Notwithstanding the foregoing or
anything to the contrary herein, the provisions of Sections
3(a) and 3(b) shall not apply: (i) to sales of up to
$2,500,000 of Shares by Gallagher to one or more accredited
investors (as defined in Regulation D under the Securities Act)
which is completed on or before June 30, 2005; (ii) to any transfer
of Allee’s Shares to Gallagher as a result of the pledge
agreement currently in effect; (iii) in the case of any Member that
is an entity, upon a transfer by such Member to its stockholders,
members, partners or other equity holders as a distribution in
respect of such persons’ ownership interests in such Member,
(iv) pursuant to a Qualified Public Offering or a Sale of the
Company, (v) in the case of any Member that is a natural person,
upon a transfer of Shares by such Member, either during his or her
lifetime or on death by will or intestacy to his or her siblings,
lineal antecedents or descendents, spouse or any custodian or
trustee for the account of such Member or such Member’s
siblings, lineal antecedents or descendents, or spouse, or (vi) to
a sale of Shares on a public trading market if there is an
established trading market for the Shares; provided, however,
notwithstanding any such permitted transfer, such transferred
Shares (except in the case of a transfer under clause
(v)
12
above) shall remain Company
Securities for all purposes hereunder, and such transferee shall be
treated as a Member (but only with respect to the securities so
transferred to the transferee) for all purposes of this Agreement
(including the obligations of a Member with respect to Proposed
Transfers of such Shares pursuant to Section 3 ); and
provided, further, in the case of any transfer pursuant to clause
(iii) or (v) hereof, that such transfer is made pursuant to a
transaction in which there is no consideration actually paid for
such transfer.
5.
Preemptive Rights .
(a)
Grant of Rights . Subject to the terms and conditions
specified in this Section 5 , in the event the Company
proposes to offer or sell any New Securities, the Company shall
first make an offering of such New Securities to each Investor and
each Series B Holder (for purposes of this Section 5 , the
Investors and the Series B Holders are referred to collectively as
the “ Offerees ”) in accordance with the
following provisions:
(i)
The Company shall deliver written notice (each, an “
Offer Notice ”) to each Offeree stating (i) its
intention to offer such New Securities, (ii) the number of such New
Securities to be offered, and (iii) the price and terms, if any,
upon which it proposes to offer such New Securities.
(ii)
By written notification delivered to the Company, within twenty
(20) calendar days after the Offer Notice is given, each Offeree
may elect to purchase, at the price and on the terms specified in
the Offer Notice, up to that portion of such New Securities equal
to the product obtained by multiplying (i) the number of shares of
New Securities specified in the applicable Offer Notice, multiplied
by (ii) a fraction, the numerator of which is the number of Common
Shares and Conversion Shares of such Offeree immediately prior to
the consummation of the proposed issuance of New Securities and the
denominator of which is the total number of Common Shares and
Conversion Shares of all Members immediately prior to the
consummation of the proposed issuance of New Securities. The
Company shall promptly, in writing, inform each Offeree that elects
to purchase all the shares of New Securities available to it, each,
a “ Fully-Exercising Offeree ”) of any
other Offeree’s failure to do likewise. During the ten (10)
day period commencing after receipt of such information, each
Fully-Exercising Offeree shall be entitled to purchase that portion
of New Securities for which the Offerees were entitled to subscribe
but which were not subscribed for by the Offerees which is equal to
the proportion that the number of Common Shares and Conversion
Shares of such Fully-Exercising Offeree bears to the total number
of Common Shares and Conversion Shares of all Fully-Exercising
Offerees who wish to purchase such unsubscribed shares.
(iii)
If all New Securities referred to in the Offer Notice are not
elected to be purchased as provided in Section 5(a)(ii)
hereof, the Company may, during the ninety (90) day period
following the expiration of the period provided in Section
5(a)(ii) hereof, offer the remaining unsubscribed portion of
such New Securities (collectively, the “ Refused
Securities ”) along with the balance of the New
Securities to any Person or Persons at a price not less than, and
upon terms no more favorable to the purchasers thereof than, those
specified in the Offer Notice. If the Company does not enter into
an agreement for the sale of the New Securities within such period,
or if such agreement is not consummated within thirty (30) days of
the execution thereof, the right provided hereunder shall be deemed
to be revived and such New
13
Securities shall not be offered
unless first reoffered to the Investors in accordance with this
Section 5(a) .
(b)
Exempt Issuances . The right of first offer in this
Section 5 shall not be applicable to the following “
Exempt Issuances ”: (i) the issuance of Common Shares
(or options, warrants or rights exercisable for, or convertible
securities convertible into, such Common Shares) representing, in
the aggregate, not more than 500,000 Common Shares, to employees,
officers or directors of, or consultants or advisors to, the
Company or any subsidiary pursuant to share purchase or share
option plans or other arrangements that are approved by the Board,
(ii) the issuance of securities pursuant to the conversion or
exercise of convertible or exercisable securities that are
outstanding on the date hereof, or that are hereafter issued in
accordance with the provisions of this Section 5 , in each
case, that are not otherwise included in the preceding clause (i),
(iii) the issuance of securities in connection with any share
split, share dividend or recapitalization by the Company, (iv) the
issuance of securities for consideration other than cash pursuant
to a merger, consolidation, strategic alliance, acquisition or
similar business combination with any Person provided such Person
is not an Affiliate of the Company or any Existing Holder, (v) the
issuance of securities pursuant to any equipment loan or leasing
arrangement, real property leasing arrangement, or debt financing
from a bank or similar financial or lending institution, and (vi)
the issuance of securities by the Company pursuant to an effective
registration statement filed under the Securities Act.
(c)
Darley Right to Purchase Shares Upon Exempt Issuances .
Darley shall have the right to purchase Common Shares from the
Company if all of the following conditions are met: (i) there is an
Exempt Issuance which causes Darley’s Percentage Ownership to
be reduced below ten percent (10%), (ii) Darley’s Percentage
Ownership prior to the Exempt Issuance was ten percent (10%) or
more, and (iii) the Exempt Issuance is not part of the Sale of the
Company (as defined in Section 2(g)). In such event, Darley shall
have the right, exercisable within ten (10) days after receipt of
notice from the Company of such Exempt Issuance, to purchase
additional Common Shares to increase Darley’s Percentage
Ownership to ten percent (10%); provided, however, that in no event
shall Darley have the right to purchase more than an aggregate of
500,000 Common Shares under this Section 5(c) as a result of all
Exempt Issuances. The purchase price for the shares being purchased
shall be the value of the Common Shares as agreed upon by the
Company and Darley; provided that if the parties cannot agree on
such value within twenty (20) days after initially attempting to do
so, the value shall be determined by an investment bank mutually
agreed between the Company and Darley. Each such party will submit
a proposed per share value, and the investment bank will be
required to select without modification the one of two proposed
alternatives that it believes is closest to fair market value, and
that shall be the purchase price. Darley’s designee to the
Managing Board shall not participate in the determinations by the
Company under this paragraph. The closing shall be held, and the
purchase price for the additional Common Shares shall be payable by
Darley in cash, within fifteen (15) days after the price has been
determined and the Common Shares purchased shall be delivered to
Darley upon the Company’s receipt of the purchase
price.
(d)
Expiration of Rights . The rights of the Investors and
Series B Holders under this Section 5 shall expire upon the
consummation of a Qualified Public Offering.
14
6.
Registration Rights . The Company covenants and
agrees as follows:
(a)
Definitions . For purposes of this Section 6:
(i)
The term “ Act ” shall mean the Securities Act
of 1933, as amended.
(ii)
The term “ Form S-3 ” shall mean such form under
the Act as in effect on the date hereof or any registration form
under the Act subsequently adopted by the SEC which permits
inclusion or incorporation of substantial information by reference
to other documents filed by the Company with the SEC.
(iii)
The term “ Full Cooperation ” shall mean, in
connection with any underwritten offering, where, in addition to
the cooperation otherwise required by this Agreement, (a) members
of senior management of the Company (including the chief executive
officer and chief financial officer) fully cooperate with the
underwriter(s) in connection therewith and make themselves
available to participate in “road-shows” and other
customary marketing activities in such locations (domestic and
foreign) as reasonably recommended by the underwriter(s) (including
one-on-one meetings with prospective purchasers of the Registrable
Securities) and (b) the Company prepares preliminary and final
prospectuses (preliminary and final prospectus supplements in the
case of an offering pursuant to a Shelf Registration Statement) for
use in connection therewith containing such additional information
as reasonably requested by the underwriter(s) (in addition to the
minimum amount of information required by law, rule or
regulation)., In the event fewer than 2,000,000 Common Shares are
subject to the registration statement, then “Full
Cooperation” shall not require more than two days of
marketing activities by Allegiant’s management.
Notwithstanding the foregoing, the Company’s management shall
not be required to participate in the road show for more than one
registration statement filed as a result of the demand of any
Holders and the cost of any road shows shall be borne by the
selling Holders.
(iv)
The term “ Fully Marketed Underwritten Offering
” means an underwritten offering in which there is Full
Cooperation but shall not include a “registered direct”
or other agented transaction that does not involve the preparation
of a preliminary prospectus or preliminary prospectus supplement in
the case of the offering pursuant to a Shelf Registration
Statement.
(v)
The term “ Holder ” shall mean (i) each of the
Investors and Series B Holders with respect to the Registrable
Securities held by such Member (ii) any person owning or having the
right to acquire Registrable Securities or any assignee thereof in
accordance with Section 6(m) hereof and (iii) any PAR
Holder.
(vi)
The term “ 1934 Act ” shall mean the Securities
Exchange Act of 1934, as amended.
(vii)
The term “ PAR ” shall mean PAR Investment
Partners, L.P.
(viii)
The term “ PAR Holder ” shall mean PAR
Investment Partners, L.P., or any assignee thereof in accordance
with Section 6(m) hereof.
15
(ix)
The term “ PAR Registrable Securities ” shall
mean any Registrable Securities held by a PAR Holder.
(x)
The terms “ register ,”“ registered
,” and “ registration ” refer to a
registration effected by preparing and filing a registration
statement or similar document in compliance with the Act, and the
declaration or ordering of effectiveness of such registration
statement or document.
(xi)
The term “ Registrable Securities ” shall mean
(A) Common Shares issued to the Investors upon conversion of their
Series A Shares, (B) Common Shares issued to Series B Holders upon
conversion of their Series B Shares, (C) Common Shares purchased by
PAR pursuant to that certain Stock Purchase Agreement dated
November 20, 2006 by and among, inter alia, PAR, the Company and
the Sellers named therein (the “ Stock Purchase
Agreement ”) and (D) any Common Shares issued as (or
issuable upon the conversion or exercise of any warrant, right or
other security which is issued as) a dividend or other distribution
with respect to, or in exchange for or in replacement of the
securities referenced in (A), (B) or (C) above, that cannot be
publicly resold by the holder thereof without registration under
the Act or the availability of an exemption thereunder, it being
understood, for the purposes of this Agreement, that Registrable
Securities shall cease to be Registrable Securities when (1) a
registration statement covering such Registrable Securities has
been declared effective and they have been disposed of pursuant to
such effective registration statemen